EP0662839A4 - Vaccins et conjugues antigeniques. - Google Patents
Vaccins et conjugues antigeniques.Info
- Publication number
- EP0662839A4 EP0662839A4 EP92921753A EP92921753A EP0662839A4 EP 0662839 A4 EP0662839 A4 EP 0662839A4 EP 92921753 A EP92921753 A EP 92921753A EP 92921753 A EP92921753 A EP 92921753A EP 0662839 A4 EP0662839 A4 EP 0662839A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hormone
- fragment
- epitope
- immunologically equivalent
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000890 antigenic effect Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000005556 hormone Substances 0.000 abstract 6
- 229940088597 hormone Drugs 0.000 abstract 6
- 239000012634 fragment Substances 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 230000001850 reproductive effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001144—Hormones, e.g. calcitonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69233711T DE69233711D1 (de) | 1992-09-30 | 1992-09-30 | Impfstoffe zur Behandlung von Kolonkrebs |
EP01102609A EP1129724B1 (fr) | 1992-09-30 | 1992-09-30 | Vaccins pour traiter le cancer du colon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1992/008370 WO1994007530A1 (fr) | 1992-09-30 | 1992-09-30 | Vaccins et conjugues antigeniques |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01102609A Division EP1129724B1 (fr) | 1992-09-30 | 1992-09-30 | Vaccins pour traiter le cancer du colon |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0662839A1 EP0662839A1 (fr) | 1995-07-19 |
EP0662839A4 true EP0662839A4 (fr) | 1995-09-06 |
Family
ID=25677857
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01102609A Expired - Lifetime EP1129724B1 (fr) | 1992-09-30 | 1992-09-30 | Vaccins pour traiter le cancer du colon |
EP92921753A Ceased EP0662839A4 (fr) | 1992-09-30 | 1992-09-30 | Vaccins et conjugues antigeniques. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01102609A Expired - Lifetime EP1129724B1 (fr) | 1992-09-30 | 1992-09-30 | Vaccins pour traiter le cancer du colon |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP1129724B1 (fr) |
JP (1) | JPH08502062A (fr) |
AT (1) | ATE373486T1 (fr) |
AU (1) | AU679902B2 (fr) |
CA (1) | CA2145391A1 (fr) |
DE (1) | DE69233711D1 (fr) |
WO (1) | WO1994007530A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759551A (en) * | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
GB9514816D0 (en) | 1995-07-19 | 1995-09-20 | Ucli Ltd | Substances and their medical use |
US7135457B1 (en) | 1997-05-15 | 2006-11-14 | Cytogen Corporation | Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
US7053177B1 (en) | 1997-05-15 | 2006-05-30 | Cytogen Corporation | Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
US6703362B1 (en) | 1997-05-15 | 2004-03-09 | Cytogen Corporation | Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
US20020025939A1 (en) * | 1998-12-18 | 2002-02-28 | Patrick L. Iversen | Chorionic gonadortropin dna vaccines and methods |
AU6620300A (en) * | 1999-08-03 | 2001-02-19 | Ohio State University, The | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
US20030091574A1 (en) | 2001-03-23 | 2003-05-15 | Gevas Philip C. | Combination treatment of pancreatic cancer |
US20090191232A1 (en) | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
JP4689597B2 (ja) | 2003-03-28 | 2011-05-25 | レセプター バイオロジックス インク. | ガストリンホルモン免疫アッセイ |
JP2008513536A (ja) | 2004-09-22 | 2008-05-01 | レセプター バイオロジックス インコーポレイテッド | プロガストリンに対するモノクローナル抗体 |
CN101111260B (zh) * | 2005-02-04 | 2013-03-20 | 萨瓦克公司 | 存活蛋白肽疫苗 |
AU2006261342B2 (en) | 2005-06-15 | 2012-02-02 | The Ohio State University Research Foundation | Her-2 peptides |
US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
WO2011056226A1 (fr) * | 2009-11-05 | 2011-05-12 | Mercia Pharma Llc | Vaccin antigrippal avec adjuvant nanoparticulaire |
EP3624841A4 (fr) | 2017-06-15 | 2021-01-27 | Cancer Advances, Inc., | Compositions et procédés pour induire des immunités humorales et cellulaires contre des tumeurs et un cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991000107A1 (fr) * | 1989-07-03 | 1991-01-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
EP0427347A1 (fr) * | 1989-11-10 | 1991-05-15 | ENIRICERCHE S.p.A. | Peptides synthétiques utiles comme porteurs universels pour la préparation des conjugués immunogéniques el leur emploi dans le développment des vaccins synthétiques |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US4384995A (en) * | 1980-01-16 | 1983-05-24 | The Ohio State University | Antigenic modification of polypeptides |
US5006334A (en) * | 1973-05-07 | 1991-04-09 | The Ohio State University | Antigenic modification of polypeptides |
US4762913A (en) * | 1973-05-07 | 1988-08-09 | The Ohio State University | Antigenic modification of polypeptides |
US4201770A (en) * | 1973-05-07 | 1980-05-06 | The Ohio State University | Antigenic modification of polypeptides |
US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
US4302386A (en) * | 1978-08-25 | 1981-11-24 | The Ohio State University | Antigenic modification of polypeptides |
US4310455A (en) * | 1979-04-17 | 1982-01-12 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
US4855285A (en) * | 1985-12-04 | 1989-08-08 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US4882145A (en) * | 1986-12-09 | 1989-11-21 | Scripps Clinic And Research Foundation | T cell epitopes of the hepatitis B virus nucleocapsid protein |
US4886782A (en) * | 1987-02-26 | 1989-12-12 | The United States Of America As Represented By The Department Of Health And Human Services | Malarial immunogen |
-
1992
- 1992-09-30 EP EP01102609A patent/EP1129724B1/fr not_active Expired - Lifetime
- 1992-09-30 DE DE69233711T patent/DE69233711D1/de not_active Expired - Fee Related
- 1992-09-30 WO PCT/US1992/008370 patent/WO1994007530A1/fr not_active Application Discontinuation
- 1992-09-30 AT AT01102609T patent/ATE373486T1/de not_active IP Right Cessation
- 1992-09-30 AU AU28063/92A patent/AU679902B2/en not_active Expired
- 1992-09-30 EP EP92921753A patent/EP0662839A4/fr not_active Ceased
- 1992-09-30 JP JP6508977A patent/JPH08502062A/ja active Pending
- 1992-09-30 CA CA002145391A patent/CA2145391A1/fr not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991000107A1 (fr) * | 1989-07-03 | 1991-01-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
EP0427347A1 (fr) * | 1989-11-10 | 1991-05-15 | ENIRICERCHE S.p.A. | Peptides synthétiques utiles comme porteurs universels pour la préparation des conjugués immunogéniques el leur emploi dans le développment des vaccins synthétiques |
Also Published As
Publication number | Publication date |
---|---|
JPH08502062A (ja) | 1996-03-05 |
AU679902B2 (en) | 1997-07-17 |
EP1129724B1 (fr) | 2007-09-19 |
CA2145391A1 (fr) | 1994-04-14 |
ATE373486T1 (de) | 2007-10-15 |
EP1129724A2 (fr) | 2001-09-05 |
DE69233711D1 (de) | 2007-10-31 |
EP0662839A1 (fr) | 1995-07-19 |
EP1129724A3 (fr) | 2001-11-07 |
WO1994007530A1 (fr) | 1994-04-14 |
AU2806392A (en) | 1994-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0662839A4 (fr) | Vaccins et conjugues antigeniques. | |
GB2303855B (en) | Helicobacter pylori antigenic protein preparation and immunoassays | |
AUPP807399A0 (en) | Improved immunogenic lhrh composition and methods relating thereto | |
HK1014659A1 (en) | Ganglioside-klh conjugate vaccines with qs-21 | |
DE3380053D1 (en) | Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them | |
EP0716613A4 (fr) | TRAITEMENT DE LA MALADIE GASTRO-DUODENALE ASSOCIEE A UNE INFECTION PAR L'-i(HELICOBACTER PYLORI) | |
IL95867A0 (fr) | ||
DE69333448D1 (en) | P53 impfstoff | |
CA2057828A1 (fr) | Lipopeptides inducteurs de lymphocytes t cytotoxiques, et emploi comme vaccins | |
EP0881910A4 (fr) | Utilisation d'immunoconjugues pour accroitre l'efficacite des vaccins multietapes stimulant les reactions immunitaires en cascade | |
EP0359919A3 (en) | Recombinant mycoplasma hyopneumoniae antigen and uses therefor | |
AU7004894A (en) | Synthetic peptides and vaccines against parvovirus | |
EP0282501A1 (fr) | Regulation de la reproduction animale | |
GR3036369T3 (en) | Vaccines based on streptokinase. | |
EP0502100A4 (en) | Reduced-protein subunit vaccine for swine dysentery | |
de Pilar | Antibodies for developing adolescents and children. Conclusions for vaccinations against rubella, measles, mumps, diphtheria and tetanus.). | |
DE69012328D1 (de) | Srif-verwandte peptide und deren verwendungen. | |
MX9700215A (es) | Proteinas y vacunas de helicobacter. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950324 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE |
|
A4 | Supplementary search report drawn up and despatched | ||
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE |
|
RHK1 | Main classification (correction) |
Ipc: A61K 39/00 |
|
17Q | First examination report despatched |
Effective date: 19961104 |
|
APAB | Appeal dossier modified |
Free format text: ORIGINAL CODE: EPIDOS NOAPE |
|
APAB | Appeal dossier modified |
Free format text: ORIGINAL CODE: EPIDOS NOAPE |
|
APAD | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOS REFNE |
|
APAB | Appeal dossier modified |
Free format text: ORIGINAL CODE: EPIDOS NOAPE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 19980507 |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |